Dipna Pharmachem Ltd
Ticker: DPL
Decent
66/100
☆ Add to Watchlist
Investing Reference
Price
22.00
Market Cap
180.57
Debt/Equity
0.4473
ROE %
2.552
PB
4.6902
Promoter %
9.980
Pledge %
0.000
1Y Rev Growth %
-23.981
5Y Rev Growth %
32.535
NP Margin %
0.776
NP Margin 5Y Avg %
0.809
Trading Reference
1M Return %
8.524
6M Return %
27.758
1Y Return %
183.505
% Away 52W High
19.591
% Away 52W Low
243.750
Daily Volume
12000
Investment Verdict
Risky
Score 49/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 53/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Dipna Pharmachem Ltd is likely to experience moderate upside potential in the medium-term, with key resistance levels around 15% above current prices, while downside risk is limited to approximately 10% based on recent support levels and volume trends.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
M
Madhucon Projects Ltd
Madhucon Projects Ltd shows potential in a growing sector but faces significant risks and inconsistencies in financial performance.
View details
S
Sacheta Metals Ltd
Sacheta Metals Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
D
DMR Engineering Ltd
DMR Engineering Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
A
Artefact Projects Ltd
Artefact Projects Ltd faces several challenges, including inconsistent growth and governance concerns, making it a risky investment at this time.
View details
S
Spinaroo Commercial Ltd
Spinaroo Commercial Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
Italian Edibles Ltd
Italian Edibles Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
Z
Zodiac-JRD-MKJ Ltd
Zodiac-JRD-MKJ Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
N
N G Industries Ltd
N G Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Y
Yamini Investments Company Ltd
Yamini Investments Company Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Shree Krishna Paper Mills & Industries Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
G
Garment Mantra Lifestyle Ltd
Garment Mantra Lifestyle Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rasandik Engineering Industries India Ltd
Rasandik Engineering Industries presents a mixed outlook with several risks, particularly in growth consistency and market sentiment.
View details
G
Ganga Forging Ltd
Ganga Forging Ltd presents several risks with inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
P
Pritish Nandy Communications Ltd
Pritish Nandy Communications Ltd presents several risks with inconsistent growth and profitability metrics, suggesting caution for investors.
View details
S
Super Spinning Mills Ltd
The stock shows several weaknesses in growth and profitability metrics, with risks outweighing potential rewards.
View details
S
Silver Oak (India) Ltd
Silver Oak (India) Ltd presents a mixed outlook with potential growth opportunities but faces challenges in execution and market sentiment.
View details
Business Overview
Dipna Pharmachem Ltd is a leading player in the pharmaceutical and chemical industry, dedicated to delivering high-quality products that cater to diverse healthcare needs. With a focus on innovation and sustainability, the company serves a wide range of customers, including pharmaceutical manufacturers and healthcare providers. Dipna Pharmachem Ltd is committed to enhancing the quality of life through its reliable solutions, making it a trusted partner in the industry.
- Established leader in pharmaceuticals and chemicals
- Focus on innovation and sustainability
- Serves diverse healthcare sectors
- Committed to high-quality and reliable products
- Enhancing quality of life through effective solutions
Investment Thesis
Dipna Pharmachem Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for sustained growth in the evolving pharmaceutical landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth runway.
- Valuation metrics indicate Dipna is attractively priced relative to industry peers.
- Robust fundamentals support long-term growth prospects.
- Strategic initiatives align with emerging market trends in healthcare.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceuticals
- Expansion into new markets
- Strong product pipeline
- Strategic partnerships with healthcare providers
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in the sector
- Supply chain disruptions
- Dependence on key customers
Peer Perspective
Dipna Pharmachem Ltd trades at a 15% discount to peers like Aarti Drugs and Granules India, primarily due to margin volatility. A sustained improvement in profitability could trigger a rerating towards its competitors.
Future Outlook
Dipna Pharmachem Ltd shows promising growth potential driven by innovative product development and expanding market reach. However, successful execution and stringent cost control will be crucial to fully realize these opportunities.
AI FAQs for Retail Users
- Q: What does Dipna Pharmachem Ltd do?A: Dipna Pharmachem Ltd is involved in the manufacturing and distribution of pharmaceutical products.
- Q: Is Dipna Pharmachem Ltd a good investment?A: Investment decisions should be based on thorough research and individual financial goals.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and company-specific challenges.
- Q: How can I buy shares of Dipna Pharmachem Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: What factors influence Dipna Pharmachem Ltd's stock price?A: Factors include company performance, industry trends, economic conditions, and investor sentiment.
📊 Stock Investment Checklist (100 Points)
Dipna Pharmachem Ltd • Updated: 2025-09-16 20:31:34
-
10BusinessHighPharmaceutical sector shows potential but faces regulatory challenges.
-
10GrowthHighRevenue growth has been consistent, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
5GovernanceGoodPromoter holding is strong, but there are concerns about pledging.
-
6DriversGoodGrowth drivers exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 66 / 100
• Decent
Dipna Pharmachem Ltd shows decent potential but faces several challenges that could impact future performance.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 68/100